NCT03495128

Brief Summary

Space flight is associated with detrimental changes to the human body, including bone and muscle loss, fluid changes and deconditioning of muscles in the heart and blood vessels. Bed rest experiments, on Earth, are used to study these changes in healthy volunteers, as the disuse of muscles, and impact on the body, mimic the changes seen in the low-gravity environment of Space. Moreover, these changes are similar to those reported in people who remain in bed for long periods of time, such as is seen in intensive care or stroke patients, and bed rest studies also allow the physiological and biochemical impacts of this confinement to be investigated. For example, we know from previous research that muscle inactivity can lead to the development of resistance to the action of the hormone 'insulin', which is a longer term risk factor for the development of type 2 diabetes. Previous studies suggest that this inactivity-induced insulin resistance occurs within the first 48 hours of immobilization. However, it is not clear whether the biochemical and physiological processes underlying these short-term responses to inactivity are the same as those seen in the longer term. The current study aims to investigate the biochemical and physiological changes seen after 3 days of bed rest and to compare to those measured in a previous 57 days bed rest study carried out at Institut Médecine Physiologie Spatiale (MEDES; Toulouse, France). A 3-day period of reconditioning will subsequently be used to determine if these changes can be readily reversed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 8, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 30, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 11, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2018

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

January 3, 2025

Status Verified

January 1, 2025

Enrollment Period

7 months

First QC Date

March 30, 2018

Last Update Submit

January 2, 2025

Conditions

Keywords

muscle protein breakdowninactivitybed rest

Outcome Measures

Primary Outcomes (1)

  • Change in Insulin stimulated whole body glucose uptake

    Determined during a hyperinsulinemic, euglycemic clamp

    after 3 days of bed rest, compared to pre-bed rest

Secondary Outcomes (18)

  • Change in Insulin stimulated whole body glucose uptake

    after 3 days of reconditioning, compared to post-bed rest

  • Change in Insulin stimulated leg glucose uptake

    after 3 days of bed rest, compared to pre-bed rest

  • Change in Insulin stimulated leg glucose uptake

    after 3 days of reconditioning, compared to post- bedrest

  • Change in Whole body muscle mass

    after 3 days of bed rest, compared to pre-bed rest

  • Change in Whole body muscle mass

    after 3 days of reconditioning, compared to post- bed rest

  • +13 more secondary outcomes

Study Arms (2)

Bed rest

EXPERIMENTAL

Three days of bed rest at -6 degrees of head-down tilt

Other: Bed Rest

Reconditioning

EXPERIMENTAL

Three days of one-legged knee extension contractions to recondition one leg

Other: Reconditioning

Interventions

3 days of head down tilt (-6 degrees) bed rest

Bed rest

daily resistance training (for 3 days) on one leg

Reconditioning

Eligibility Criteria

Age20 Years - 45 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Physically and mentally healthy participants
  • Body mass index 20 - 26 kg/m2
  • Height 158 - 190 cm (62 - 75 inches),
  • Participants that are able to consent to participation in the entire study
  • Signed informed consent

You may not qualify if:

  • regular use of prescribed or 'over-the counter' medication
  • Bone mineral density (measured by Dual-Energy X-ray Absorptiometry) more than 1.5 standard deviation less than t-score
  • Family history of thrombosis or positive response in thrombosis blood screening: Antithrombin III, High sensitive C-Reactive Protein, protein kinase B, F-V-Leiden, Prothrombin mutation, Lupus-prothrombin time, Factor II
  • Any current medical condition
  • A medical history of thyroid dysfunction, renal function disorder (including renal stones), diabetes, cardiac arrhythmias and cardiovascular disorders, migraines, allergies, hypertension, hypocalcaemia, uric acidaemia, lipidemia or hyperhomocysteinemia, hiatus hernia, bowel surgery or gastro-oesophageal reflux
  • History of a mental health disorder
  • Smoker within six months prior to the start of the study
  • Dependence on drugs, medicine or alcohol
  • History of orthostatic intolerance, vestibular disorders or claustrophobia
  • Special food diet, vegetarian or vegan, history of intolerance to lactose or food allergy,
  • Osteosynthesis material, presence of metallic implants, history of knee problems or joint surgery/broken leg,
  • Orthopaedic or musculoskeletal disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

David Greenfield Human Physiology Laboratories

Nottingham, Notts, NG72UH, United Kingdom

Location

Related Publications (5)

  • Bergouignan A, Rudwill F, Simon C, Blanc S. Physical inactivity as the culprit of metabolic inflexibility: evidence from bed-rest studies. J Appl Physiol (1985). 2011 Oct;111(4):1201-10. doi: 10.1152/japplphysiol.00698.2011. Epub 2011 Aug 11.

    PMID: 21836047BACKGROUND
  • Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT; Lancet Physical Activity Series Working Group. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012 Jul 21;380(9838):219-29. doi: 10.1016/S0140-6736(12)61031-9.

    PMID: 22818936BACKGROUND
  • DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214-23. doi: 10.1152/ajpendo.1979.237.3.E214.

    PMID: 382871BACKGROUND
  • Brook MS, Wilkinson DJ, Mitchell WK, Lund JN, Phillips BE, Szewczyk NJ, Greenhaff PL, Smith K, Atherton PJ. Synchronous deficits in cumulative muscle protein synthesis and ribosomal biogenesis underlie age-related anabolic resistance to exercise in humans. J Physiol. 2016 Dec 15;594(24):7399-7417. doi: 10.1113/JP272857. Epub 2016 Nov 7.

    PMID: 27654940BACKGROUND
  • Shur NF, Simpson EJ, Crossland H, Chivaka PK, Constantin D, Cordon SM, Constantin-Teodosiu D, Stephens FB, Lobo DN, Szewczyk N, Narici M, Prats C, Macdonald IA, Greenhaff PL. Human adaptation to immobilization: Novel insights of impacts on glucose disposal and fuel utilization. J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2999-3013. doi: 10.1002/jcsm.13075. Epub 2022 Sep 4.

MeSH Terms

Conditions

Muscular AtrophyInsulin ResistanceSedentary Behavior

Interventions

Bed Rest

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesBehavior

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Paul L Greenhaff, PhD

    University of Nottingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: longitudinal assessment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Research Fellow

Study Record Dates

First Submitted

March 30, 2018

First Posted

April 11, 2018

Study Start

January 8, 2018

Primary Completion

July 31, 2018

Study Completion

December 31, 2019

Last Updated

January 3, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations